93 filings
Page 4 of 5
8-K
uqvrd 6uxtz0i6s5
9 May 19
UroGen Pharma Reports First Quarter 2019 Financial Results and Recent
8:12am
8-K
6bwk60
28 Feb 19
UroGen Pharma to Report Fourth Quarter and Full Year 2018 Financial Results
8:16am
8-K
qqoajhih tp2f1hov
25 Jan 19
UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares
7:30am
8-K
n5lb0
22 Jan 19
UroGen Pharma Announces Proposed Public Offering of Ordinary Shares
5:08pm
8-K
t0aagvti p8aa9
9 Jan 19
UroGen Pharma Announces Positive Results ofUGN-101 from Pivotal
12:48pm
8-K
nb2i spsq5rz
4 Jan 19
Departure of Directors or Certain Officers
12:00am
6-K
qzssl5bj
13 Nov 18
Current report (foreign)
6:33am
6-K
77rj44
31 Oct 18
UGN-101 Joins Select Group of Urologic Oncology Product Candidates to Receive BTD
3:36pm
6-K
zyfwbp140zxtf2pxqms
1 Oct 18
Current report (foreign)
12:00am
6-K
r8q8fj
21 Sep 18
Current report (foreign)
8:05am
6-K
8hm gpbeyu04ncix5e7
18 Sep 18
Current report (foreign)
12:00am
6-K
pni q8k92os4m8n
30 Aug 18
Current report (foreign)
12:00am
6-K
2afu b1fnp8cg
14 Aug 18
Current report (foreign)
4:09pm
6-K
2ylb3
8 Aug 18
UroGen Pharma Appoints Peter P. Pfreundschuh as Chief Financial Officer
1:46pm
6-K
nml9gulo7buufuw5922
12 Jul 18
UroGen Pharma Appoints Shawn Cline Tomasello to its Board of Directors
8:07pm
6-K
t7edh2 dkwe5laq8k
6 Jun 18
UroGen Pharma Announces Stephen Mullennix as Interim Chief Financial Officer and Jason Patel as Vice President of Finance
2:03pm
6-K
5wqbtx
6 Jun 18
Current report (foreign)
2:01pm
6-K
a005qzdyq bsyj
15 May 18
Current report (foreign)
4:24pm
6-K
a3k gq2u5
25 Apr 18
Current report (foreign)
4:04pm
6-K
qm6l0i5sprtpcfw8o
4 Apr 18
Current report (foreign)
12:00am